
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study
Rafaella Fortini Queiroz Grenfell, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Rafaella Fortini Queiroz Grenfell, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Showing 18 citing articles:
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis
Xiaoyin Zhang, Jiayue Xia, Lairun Jin, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 11
Xiaoyin Zhang, Jiayue Xia, Lairun Jin, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 11
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
Guilherme Rodrigues Fernandes Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 18
Guilherme Rodrigues Fernandes Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 18
Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination
Ana Eliza Garcia Ralise, Taís Mendes Camargo, Fernando Augusto Lima Marson
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 10
Ana Eliza Garcia Ralise, Taís Mendes Camargo, Fernando Augusto Lima Marson
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 10
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
Yuxiao Wang, Ying Qiao, Yuqi Huo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Yuxiao Wang, Ying Qiao, Yuqi Huo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Efetividade das vacinas da COVID-19 e disseminação do vírus: revisão sistemática
Gabriely Quintana de Medeiros, Vitória Neves de Barros, Vitor Martins Guesser, et al.
Revista Neurociências (2023) Vol. 31, pp. 1-23
Open Access | Times Cited: 5
Gabriely Quintana de Medeiros, Vitória Neves de Barros, Vitor Martins Guesser, et al.
Revista Neurociências (2023) Vol. 31, pp. 1-23
Open Access | Times Cited: 5
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up
Camila Amormino Corsini, Priscila Fernanda da Silva Martins, Priscilla Soares Filgueiras, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Camila Amormino Corsini, Priscila Fernanda da Silva Martins, Priscilla Soares Filgueiras, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors
Thiago Alonso Stephan Lacerda de Sousa, Nathalie Bonatti Franco Almeida, Fabrício Aparecido dos Santos, et al.
Nanotechnology (2024) Vol. 35, Iss. 42, pp. 425503-425503
Open Access | Times Cited: 1
Thiago Alonso Stephan Lacerda de Sousa, Nathalie Bonatti Franco Almeida, Fabrício Aparecido dos Santos, et al.
Nanotechnology (2024) Vol. 35, Iss. 42, pp. 425503-425503
Open Access | Times Cited: 1
Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants
Cecília Ártico Banho, Beatriz de Carvalho Marques, Lívia Sacchetto, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Cecília Ártico Banho, Beatriz de Carvalho Marques, Lívia Sacchetto, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Effectiveness of CoronaVac versus BNT162b2 based on neutralizing antibody response: A systematic review
Zeynep Ece Kuloğlu, Şiran Keske, Mert Ahmet Kuşkucu, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 621-624
Closed Access | Times Cited: 1
Zeynep Ece Kuloğlu, Şiran Keske, Mert Ahmet Kuşkucu, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 621-624
Closed Access | Times Cited: 1
COVID-19 vaccination status, side effects, and perceptions among breast cancer survivors: a cross-sectional study in China
Yali Xu, Linrong Li, Xiaomeng Li, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Yali Xu, Linrong Li, Xiaomeng Li, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J. Chappell, Francesca L. Mordant, Alberto A. Amarilla, et al.
EBioMedicine (2023) Vol. 97, pp. 104842-104842
Open Access | Times Cited: 2
Keith J. Chappell, Francesca L. Mordant, Alberto A. Amarilla, et al.
EBioMedicine (2023) Vol. 97, pp. 104842-104842
Open Access | Times Cited: 2
Population-Based Analysis of the Immunoglobulin G Response to Different COVID-19 Vaccines in Brazil
Nigella M. Paula, Marcelo S. Conzentino, Ana Carolina Aparecida Gonçalves, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 21-21
Open Access | Times Cited: 4
Nigella M. Paula, Marcelo S. Conzentino, Ana Carolina Aparecida Gonçalves, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 21-21
Open Access | Times Cited: 4
Dynamic clade transitions and the influence of vaccine rollout on the spatiotemporal circulation of SARS-CoV-2 variants in São Paulo, Brazil
Maurício Lacerda Nogueira, Cecília Ártico Banho, Beatriz Marques, et al.
Research Square (Research Square) (2024)
Open Access
Maurício Lacerda Nogueira, Cecília Ártico Banho, Beatriz Marques, et al.
Research Square (Research Square) (2024)
Open Access
Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol
Guilherme Rodrigues Fernandes Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Guilherme Rodrigues Fernandes Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Evaluating long-term antibody responses to booster doses of COVID-19 vaccines in the Pakistani population
Shakir Hussain, Fouzia Naseer, Fatima Kanani, et al.
Pakistan Journal of Medical Sciences (2023) Vol. 40, Iss. 2(ICON)
Open Access | Times Cited: 1
Shakir Hussain, Fouzia Naseer, Fatima Kanani, et al.
Pakistan Journal of Medical Sciences (2023) Vol. 40, Iss. 2(ICON)
Open Access | Times Cited: 1
Acute perimyocarditis following heterologous vaccination of CoronaVac and BNT162b2 SARS-CoV-2 vaccine in an elderly woman.
Shing Ching, Chiu Sun Yue
PubMed (2022) Vol. 19, Iss. 10, pp. 785-787
Closed Access | Times Cited: 1
Shing Ching, Chiu Sun Yue
PubMed (2022) Vol. 19, Iss. 10, pp. 785-787
Closed Access | Times Cited: 1
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection
Camila Amormino Corsini, Priscilla Soares Filgueiras, Nathalie Bonatti Franco Almeida, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
Camila Amormino Corsini, Priscilla Soares Filgueiras, Nathalie Bonatti Franco Almeida, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access